CV Sciences (CVSI) Non-Current Assets (2013 - 2026)
CV Sciences (CVSI) reported Non-Current Assets of $1.7 million for Q1 2026, down 3.95% on a YoY basis from $1.8 million in Q1 2025, and down 5.58% sequentially from $1.8 million in Q4 2025.
CV Sciences (CVSI) Non-Current Assets (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Non-Current Assets data on file, last reported at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 3.95% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 1067.83% YoY), and the FY2025 full-year result was $1.8 million, up 8.61% from the prior year.
- Non-Current Assets declined to $1.7 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $3.2 million in Q1 2022 to a low of -$6.4 million in Q3 2024.
- A 5-year average of $1.4 million and a median of $1.7 million in 2026 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets sank 637.05% in 2024 and surged 129.62% in 2025, its largest moves.
- Tracing CVSI's Non-Current Assets over 5 years: stood at $1.6 million in 2022, then dropped by 21.42% to $1.3 million in 2023, then jumped by 33.44% to $1.7 million in 2024, then grew by 8.61% to $1.8 million in 2025, then dropped by 5.58% to $1.7 million in 2026.
- Business Quant data shows CVSI's Non-Current Assets at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | -6.41 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 3.12 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.88 Mn |
| Sep 30, 2021 | 9.40 Mn |
| Jun 30, 2021 | 12.78 Mn |